ALT 与 qHBsAg 的比值可预测接受 Peg-IFN-α 治疗的 HBeAg 阴性乙型肝炎患者的 HBsAg 血清清除率

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Journal of Hepatology Pub Date : 2024-10-17 DOI:10.1016/j.jhep.2024.10.008

Jian Wang, Qun Zhang, Shaoqiu Zhang, Chao Wu, Rui Huang

{"title":"ALT 与 qHBsAg 的比值可预测接受 Peg-IFN-α 治疗的 HBeAg 阴性乙型肝炎患者的 HBsAg 血清清除率","authors":"Jian Wang, Qun Zhang, Shaoqiu Zhang, Chao Wu, Rui Huang","doi":"10.1016/j.jhep.2024.10.008","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Contributors</h2>Jian Wang: Conceptualization; writing – original draft. Qun Zhang: writing – original draft. Shaoqiu Zhang: writing – original draft. Chao Wu: Conceptualization; writing – review and editing. Rui Huang: Conceptualization; writing – original draft; writing – review and editing; supervision.</section></section><section><section><h2>Financial support</h2>This work was supported by grants of Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (No. 2022-LCYJ-MS-07 and 2021-LCYJ-PY-43).</section></section><section><section><h2>Declaration of Competing Interest</h2>None.</section></section><section><section><h2>Acknowledgements</h2>We thank Chuanwu Zhu and Weimao Ding for data support.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"1 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ALT to qHBsAg ratio predicts HBsAg seroclearance in HBeAg-negative hepatitis B patients with Peg-IFN-α-based therapy\",\"authors\":\"Jian Wang, Qun Zhang, Shaoqiu Zhang, Chao Wu, Rui Huang\",\"doi\":\"10.1016/j.jhep.2024.10.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h2>Section snippets</h2><section><section><h2>Contributors</h2>Jian Wang: Conceptualization; writing – original draft. Qun Zhang: writing – original draft. Shaoqiu Zhang: writing – original draft. Chao Wu: Conceptualization; writing – review and editing. Rui Huang: Conceptualization; writing – original draft; writing – review and editing; supervision.</section></section><section><section><h2>Financial support</h2>This work was supported by grants of Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (No. 2022-LCYJ-MS-07 and 2021-LCYJ-PY-43).</section></section><section><section><h2>Declaration of Competing Interest</h2>None.</section></section><section><section><h2>Acknowledgements</h2>We thank Chuanwu Zhu and Weimao Ding for data support.</section></section>\",\"PeriodicalId\":15888,\"journal\":{\"name\":\"Journal of Hepatology\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":26.8000,\"publicationDate\":\"2024-10-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jhep.2024.10.008\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2024.10.008","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

章节片段贡献者王健：构思；撰写-原稿。Qun Zhang：撰写-原稿。Shaoqiu Zhang：撰写-原稿。吴超构思；写作--审阅和编辑。黄锐：构思；撰写-原稿；撰写-审阅和编辑；指导。财务支持本工作得到了南京大学医学院附属鼓楼医院临床试验基金的支持（编号：2022-LCYJ-MS-07 和 2021-LCYJ-PY-43）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

ALT to qHBsAg ratio predicts HBsAg seroclearance in HBeAg-negative hepatitis B patients with Peg-IFN-α-based therapy

Section snippets

Contributors

Jian Wang: Conceptualization; writing – original draft. Qun Zhang: writing – original draft. Shaoqiu Zhang: writing – original draft. Chao Wu: Conceptualization; writing – review and editing. Rui Huang: Conceptualization; writing – original draft; writing – review and editing; supervision.

Financial support

This work was supported by grants of Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (No. 2022-LCYJ-MS-07 and 2021-LCYJ-PY-43).

Declaration of Competing Interest

None.

Acknowledgements

We thank Chuanwu Zhu and Weimao Ding for data support.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.

期刊最新文献

PLEX for Acute Liver Failure in UK National Cohort: A situation perplexed! Reply to: “Insights into Fracture Risk with Tenofovir and Entecavir: Evidence from Pharmacovigilance Data” Mastering the Narrative: Precision Reporting of Risk and Outcomes in Liver Transplantation Contents Editorial Board